<DOC>
	<DOC>NCT00315107</DOC>
	<brief_summary>Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.</brief_summary>
	<brief_title>Estrogen Treatment in Acromegalic Women</brief_title>
	<detailed_description>This will be a canadian multicenter study with a randomized, double-blind, placebo-controlled design, to assess the efficacy and safety of adjuvant alesse in female acromegalic patients with suboptimal response to sandostatin LAR treatment.</detailed_description>
	<mesh_term>Acromegaly</mesh_term>
	<criteria>Women 18 years and older treated with somatostatin analogs Active acromegaly Cardiovascular or cerebrovascular disease Thrombophlebitis or thromboembolism Breast cancer Noncontrolled arterial hypertension Smoking Pregnancy or lactation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
</DOC>